The objectives of the project include:
i) the determination of the between-herd prevalence of paratuberculosis in Swiss dairy herds based on a well-established serological method (ELISA), so that the estimation of the true prevalence will be possible based on the test results and characteristics,
ii) the determination of the within-herd prevalence of paratuberculosis in infected dairy herds, which is complementary to the between-herd prevalence in order to assess the countrywide relevance of the disease,
iii) the identification of risk factors associated with a positive herd status and a high within-herd prevalence regarding paratuberculosis in a representative sample of Swiss dairy farms, in order to identify management factors associated with introduction and spread of MAP in infected herds.
This grant application (project abstract, Projektskizze) was submitted (in March 2020) jointly with another research project aimed at taking the next logical step in addressing paratuberculosis in Swiss dairy herds, i.e. the development of recommendations for the design of control strategies based on the results of objectives i) to iii) above. The objective of this second project was to evaluate the suitability of several rapid and affordable diagnostic methods to determine the infection status of Swiss dairy herds (infected vs. free of paratuberculosis). The results from analyses of different matrices (serum, milk, environmental samples), sampling strategies (e.g. individual milk samples vs. repeated bulk tank milk samples, whole herd serology vs. subset of animals with the highest risk) and methods (ELISA, PCR), and combinations thereof should be explored to define the accuracy of different strategies for determination of the infection status of dairy herds. The most adequate strategy may then be used for certification programs in Swiss dairy herds.
Although the FSVO decided last spring to pursue the seroprevalence study only in a first step, a detailed description of synergies between the two projects was requested (Auflage gemäss BLV-Antwortschreiben vom 8.5.2020) with the full project description of the seroprevalence study. These synergies and the consequences of not taking advantage therof for the realization of the seroprevalence project and for the evaluation of diagnostic strategies are depicted below in 6.4. (Methods) and 6.5. (Time schedule).